Adicet Bio, Inc. (ACET) delivered a return of 932.18% over the past year. Since ACET does not currently pay dividends, the total return equals the price-only return.

A $10,000 investment in Adicet Bio, Inc. one year ago would be worth $103,218 today, representing a gain of $93,218.

Adicet Bio, Inc. (ACET) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends. For ACET, the total return equals the price-only return.

Yes, Adicet Bio, Inc. (ACET) outperformed the S&P 500 by 909.33 percentage points over the past year. ACET delivered a total return of 932.18%, compared to the S&P 500's 22.86%. This 909.33pp alpha means investors in ACET earned more than a passive S&P 500 index fund.

Adicet Bio, Inc. (ACET) experienced a maximum drawdown of -54.81% over the past year, declining from its peak on 2025-10-16 to its trough on 2025-12-17. The stock recovered to its prior peak by 2025-12-29. Maximum drawdown measures the worst peak-to-trough decline and is an important risk metric for investors.

Here are Adicet Bio, Inc. (ACET)'s long-term returns with dividends reinvested. Over 10 years, the total return is -92.8% (-23.1% CAGR) — $10,000 would have grown to $721. Over 20 years: -91.4% total return (-11.5% CAGR) — $10,000 → $861. Over 30 years: -91.4% total return (-7.8% CAGR) — $10,000 → $861. Long-term investors benefit from compounding: dividends buy additional shares, which generate their own dividends, creating an exponential growth effect.

Adicet Bio, Inc.'s best calendar year was 2025 with a total return of 764.7%. Its worst year was 2019 with a total return of -83.3%. This range shows the volatility investors should expect — the difference between the best and worst year is 847.9 percentage points.